share_log

Morgan Stanley Maintains Overweight on LifeStance Health Gr, Raises Price Target to $10

Morgan Stanley Maintains Overweight on LifeStance Health Gr, Raises Price Target to $10

摩根士丹利维持对LifeStance Health Gr的增持,将目标股价上
Benzinga ·  2023/05/11 08:26

Morgan Stanley analyst Ricky Goldwasser maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $8 to $10.

摩根士丹利分析师瑞奇·戈德瓦瑟维持LifeStance Health Gr(纳斯达克股票代码:LFST)的增持,并将目标股价从8美元上调至10美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发